首页> 美国卫生研究院文献>BMC Gastroenterology >Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions
【2h】

Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions

机译:尿中性粒细胞明胶酶相关的脂钙素:住院的肝硬化性AKI易患患者的急性肾损伤(AKI)的诊断和预后标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAcute kidney injury (AKI) is known to increase mortality in hospitalized cirrhotic patients; therefore early identification is utmost significance. There are only a few studies evaluating the cut-off level of urine neutrophil gelatinase-associated lipocalin (uNGAL) for diagnosing AKI and its prognostic value in cirrhotic patients. We aimed to determine the accuracy of uNGAL as a biomarker for early identification of AKI and to determine the cut-off level of uNGAL for diagnosing AKI in hospitalized cirrhotic patients; and (2) to explore the association of 30-day liver-related mortality with uNGAL level.
机译:背景:急性肾损伤(AKI)已知会增加住院肝硬化患者的死亡率;因此,尽早识别是最重要的。仅有少数研究评估尿中性粒细胞明胶酶相关脂质运载蛋白(uNGAL)的临界水平在肝硬化患者中诊断AKI及其预后价值。我们旨在确定uNGAL作为早期识别AKI的生物标记物的准确性,并确定uNGAL的临界水平以诊断肝硬化住院患者的AKI。 (2)探讨30天肝脏相关死亡率与uNGAL水平的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号